← Leaderboards
Charles S Cobbs
Institute For Systems Biology
$4,909,864
Attributed
$7,097,628
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,097,628 · 5
By mechanism
R01$6,672,001 · 3
R21$425,627 · 1
P50$0 · 1
Top collaborators
- Nitin S Baliga4 shared
- Parvinder Hothi4 shared
- Brian Chih-Seng Searle2 shared
Most similar at Institute For Systems Biology
Same institution · by research overlap
- Marjorie Carole Brand$1,676,182
- John D. Aitchison$21,681,686
- Nitin S Baliga$23,717,027
- Theodore Perkins$522,000
- Parvinder Hothi$987,475
Others in their field
Top investigators on “Glioblastoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$50,454,235
- John H Sampson · Duke University$34,869,540
- Walter John Curran · Thomas Jefferson University$27,327,059
- Jann N Sarkaria · Mayo Clinic Coll Of Medicine, Rochester$23,947,143
- Jeremy N Rich · University Of Pittsburgh At Pittsburgh$21,935,828
- Maciej S Lesniak · Northwestern University$18,837,339
Research focus
GlioblastomaPathway InteractionsGliomaTumorPhenotypeCellsApoptosisGenesBiopsyBrain NeoplasmsStem CellsBrainMalignant NeoplasmsCytomegalovirusNeoplastic CellBaseRadiation TherapyStandard Of CareAntiviral AgentsLaboratoriesDesignExhibitsImmune ResponseCharacteristics
Grant awards (16)
Systems biology of intratumoral heterogeneity in glioblastoma$738,422
R01 · FY2025 · CA
Systems biology of intratumoral heterogeneity in glioblastoma$710,570
R01 · FY2024 · CA
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma$218,604
R21 · FY2024 · CA · contact PI
Systems biology of intratumoral heterogeneity in glioblastoma$747,647
R01 · FY2023 · CA
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma$207,023
R21 · FY2023 · CA · contact PI
Systems biology of intratumoral heterogeneity in glioblastoma$765,787
R01 · FY2022 · CA
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma$424,977
R01 · FY2017 · CA · contact PI
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma$550,450
R01 · FY2016 · CA · contact PI
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma$512,013
R01 · FY2015 · CA · contact PI
The Role of Cidofovir and Structural Analogs as Adjuvant Therapy for Glioblastoma$643,177
R01 · FY2014 · CA · contact PI
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis$368,264
R01 · FY2014 · NS · contact PI
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis$371,984
R01 · FY2012 · NS · contact PI
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis$371,984
R01 · FY2011 · NS · contact PI
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis$379,575
R01 · FY2010 · NS · contact PI
Cytomegalovirus Gene Expression and Strain Variability in Glioma Pathogenesis$87,151
R01 · FY2010 · NS · contact PI
HCMV in human malignant glioma pathogenesis$0
P50 · FY2002 · CA